https://orcid.org/0000-0002-5428-1624
References
- Pusl T, Beuers U. Intrahepatic cholestasis of pregnancy. Orphanet J Rare Dis. 2007;2:1–6.
- Knox TA, Olans LB. Liver disease in pregnancy. N Engl J Med. 1996;335(8):569–576. doi:10.1056/NEJM199608223350807
- Kenyon A, Tribe RM, Nelson-Piercy C, et al. Pruritus in pregnancy: a study of anatomical distribution and prevalence in relation to the development of obstetric cholestasis. Obstetr Med. 2010;3(1):25–29. doi:10.1258/om.2010.090055
- Lee RH, Greenberg M, Metz TD, Pettker CM. Society for maternal-fetal medicine consult series# 53: intrahepatic cholestasis of pregnancy: replaces consult# 13, April 2011. Am J Obstet Gynecol. 2021;224(2):B2–B9.
- Begley NR, Beltran AF. Intrahepatic cholestasis in pregnancy: increased surveillance and the role of bile acids in a patient with history of fetal demise. Obstet Gynecol Cases Rev. 2021;8:212.
- Kamimura K, Abe H, Kamimura N, et al. Successful management of severe intrahepatic cholestasis of pregnancy: report of a first Japanese case. BMC Gastroenterol. 2014;14(1):1–5.
- Zhang L, Liu X-H, Qi H-B, et al. Ursodeoxycholic acid and S-adenosylmethionine in the treatment of intrahepatic cholestasis of pregnancy: a multi-centered randomized controlled trial. Eur Rev Med Pharmacol Sci. 2015;19(19):3770–3776.
- Glantz A, Reilly S-J, Benthin L, et al. Intrahepatic cholestasis of pregnancy: amelioration of pruritus by UDCA is associated with decreased progesterone disulphates in urine. Hepatology. 2008;47(2):544–551. doi:10.1002/hep.21987